Drug Guide

Generic Name

Deserpidine

Brand Names Harmonyl

Classification

Therapeutic: Antihypertensive

Pharmacological: Indolalkylamine

FDA Approved Indications

  • Hypertension

Mechanism of Action

Deserpidine acts by depleting catecholamines (norepinephrine and epinephrine) from sympathetic nerve endings, leading to vasodilation and decreased blood pressure.

Dosage and Administration

Adult: Typically 2.5 to 5 mg orally 2-3 times daily; dosage may be titrated based on response.

Pediatric: Use not well established; consult specific pediatric guidelines.

Geriatric: Start at lower doses due to increased sensitivity and risk of orthostatic hypotension.

Renal Impairment: Use with caution; monitor blood pressure and renal function.

Hepatic Impairment: Use caution; dose adjustments may be necessary.

Pharmacokinetics

Absorption: Orally absorbed with variable bioavailability.

Distribution: Widely distributed in body tissues.

Metabolism: Metabolized in the liver.

Excretion: Excreted primarily via the kidneys.

Half Life: Approximately 7-8 hours.

Contraindications

  • History of hypersensitivity to deserpidine or similar agents.
  • Severe depression.
  • Bradycardia.

Precautions

  • Use cautiously in patients with asthma, peptic ulcers, or hepatic impairment.
  • Monitor for orthostatic hypotension, especially in the elderly.

Adverse Reactions - Common

  • Sedation or drowsiness (Common)
  • Dry mouth (Less common)

Adverse Reactions - Serious

  • Depression or mental disturbances (Rare)
  • Orthostatic hypotension (Occasionally)
  • Bradycardia (Rare)

Drug-Drug Interactions

  • MAO inhibitors may enhance hypotensive effect.
  • Other antihypertensives may have additive effects.

Drug-Food Interactions

N/A

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor blood pressure and heart rate regularly.

Diagnoses:

  • Risk for falls due to orthostatic hypotension.
  • Ineffective health maintenance.

Implementation: Administer as prescribed, observe for adverse effects, educate patient on positional changes.

Evaluation: Assess blood pressure control and side effects.

Patient/Family Teaching

  • Take medication exactly as prescribed.
  • Rise slowly from sitting or lying position to prevent dizziness.
  • Report any signs of depression, fast heartbeat, or severe side effects.

Special Considerations

Black Box Warnings: N/A

Genetic Factors: None specific.

Lab Test Interference: None known.

Overdose Management

Signs/Symptoms: Severe hypotension, bradycardia, sedation, dizziness.

Treatment: Supportive care, intravenous fluids, atropine for bradycardia, gastric lavage if recent ingestion.

Storage and Handling

Storage: Store at room temperature, away from moisture and light.

Stability: Stable under recommended conditions.

This guide is for educational purposes only and is not intended for clinical use.